1-4 of 4
Zhenhuan Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Simone Feurstein, Amy M. Trottier, Noel Estrada-Merly, Matthew Pozsgai, Kelsey McNeely, Michael W. Drazer, Brian Ruhle, Katharine Sadera, Ashwin L. Koppayi, Bart L. Scott, Betul Oran, Taiga Nishihori, Vaibhav Agrawal, Ayman Saad, R. Coleman Lindsley, Ryotaro Nakamura, Soyoung Kim, Zhenhuan Hu, Ronald Sobecks, Stephen Spellman, Wael Saber, Lucy A. Godley
Journal: Blood
Blood (2022) 140 (24): 2533–2548.
https://doi.org/10.1182/blood.2022015790
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis

Sonali Chaudhury, MD, Nobuko HiJiya, MD, Zhenhuan Hu, MS, Rodney Sparapani, PhD, Matt E. Kalaycio, MD, Edwin P. Alyea, MD, Uday R. Popat, MD, Wael Saber, MD MS
Journal: Blood
Blood (2014) 124 (21): 2534.
https://doi.org/10.1182/blood.V124.21.2534.2534
Published: 2014
Journal Articles

Tacrolimus/Sirolimus Vs. Tacrolimus/Methotrexate for Graft-Vs.-Host Disease Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of Blood and Marrow Transplant Clinical Trials Network Trial 0402

Corey Cutler, MD, MPH, FRCPC, Brent R. Logan, PhD, Ryotaro Nakamura, MD, Laura Johnston, MD, Sung W. Choi, M.D., David L Porter, MD, William J Hogan, MBBCh, Marcelo C Pasquini, MD, MS, Margaret L. MacMillan, MD, John R. Wingard, MD, Edmund K. Waller, MD, PhD, Stephan A. Grupp, MD, PhD, Philip L. McCarthy, MD, Juan Wu, MS, Zhenhuan Hu, MPH, Shelly L Carter, ScD, Mary M. Horowitz, MD, MS, Joseph H. Antin, MD
Journal: Blood
Blood (2012) 120 (21): 739.
https://doi.org/10.1182/blood.V120.21.739.739
Published: 2012
Journal Articles

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Vikas Gupta, MD, FRCP, FRCPath, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Zhenhuan Hu, MPH, Parameswaran Hari, MBBS, MD, MRCP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Wael Saber, MD, MS
Journal: Blood
Blood (2012) 120 (21): 432.
https://doi.org/10.1182/blood.V120.21.432.432
Published: 2012